Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11661423 Heterocyclic compounds as RET kinase inhibitors

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 31 May, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 31 May, 2023
Edits made to:
Infobox (+31 properties)
‌

 US Patent 11661423 Heterocyclic compounds as RET kinase inhibitors

Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Cancer Research Technology Limited
0
Current Assignee
‌
Cancer Research Technology Limited
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116614230
Date of Patent
May 30, 2023
0
Patent Application Number
170750040
Date Filed
October 20, 2020
0
Patent Citations
‌
US Patent 7429596 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
0
‌
US Patent 7772231 Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors
0
‌
US Patent 7923555 Fused bicyclic mTor inhibitors
0
‌
US Patent 8314111 Fused bicyclic motor inhibitors
0
‌
US Patent 8501724 Purinone compounds as kinase inhibitors
0
‌
US Patent 8796455 Fused bicyclic mTOR inhibitors
0
‌
US Patent 8901134 Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders
0
‌
US Patent 9096611 Kinase inhibitors and methods of use
0
‌
US Patent 9174994 Enhanced treatment regimens using mTor inhibitors
0
‌
US Patent 9271963 Selective inhibitors of human corticosteroid synthases
0
‌
US Patent 9358229 JAK PI3K/mTOR combination therapy
0
‌
US Patent 9409911 Inhibitors of bruton's tyrosine kinase
0
‌
US Patent 9512125 Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
0
‌
US Patent 9629843 MTOR modulators and uses thereof
0
‌
US Patent 9669032 Enhanced treatment regimens using mTOR inhibitors
0
‌
US Patent 9724354 Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase
0
‌
US Patent 9765037 Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases
0
‌
US Patent 10844067 Heterocyclic compounds as RET kinase inhibitors
0
Patent Primary Examiner
‌
John M Mauro
0
CPC Code
‌
C07D 471/04
0
‌
C07D 519/00
0
‌
C07D 487/04
0
‌
A61P 35/00
0

Find more entities like US Patent 11661423 Heterocyclic compounds as RET kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo